SANTA CLARA, Calif.--(BUSINESS WIRE)--Iris BioTechnologies (OTCBB: IRSB, http://www.irisbiotech.com), a theranostics company focused on providing patients, doctors, and clinicians with improved methods of identifying effective treatment solutions, has commenced trading on the Over-the-Counter (“OTC”) market today.
